Clinikally (YC S22)
Clinikally, founded in 2021, is a pioneering Telehealth and E-Pharmacy service exclusively for skin, hair care, and nutrition based in India. The startup offers instant connection with experienced dermatologists, customized care plans, and hassle-free delivery of prescribed treatments. With a significant investment of $2.60M in the recent Seed Round on 29th September 2023, Clinikally has grabbed attention from notable investors including Y Combinator, Rebel Fund, Tanay Tandon, Qasar Younis, Austen Allred, Sequoia Capital (SSF), Kunal Shah, Deepika Bodapati, Arash Ferdowsi, and James Beshara. This backing has further solidified its position as a standout in the Health Care and Pharmaceutical industries, enabling them to continue their mission of offering expert care for skin and hair through telehealth and delivering RX-grade products. Its dedication to leveraging technology and expertise to transform the skin and hair care journey for over 10 lakh+ satisfied customers reflects its commitment to delivering meaningful solutions in the digital healthcare space. Clinikally's focus on Telehealth, E-Pharmacy, Dermatology, Nutrition, and the support from global accelerator YCombinator positions it as a key player in the Indian wellness industry, offering a unique and personalized approach that sets it apart from traditional healthcare services. With their strong value proposition and notable investor support, Clinikally is poised for significant growth and impact in the Indian digital healthcare market.
No recent news or press coverage available for Clinikally (YC S22).